Uxin Ltd UXIN
Business Services · IPO 2018 · data as of November 13, 2026
Uxin Ltd (UXIN) is a consumer discretionary company listed in the US with a market value of about $178M. In fiscal year 2025 it had revenue of $463M and net income of -$40M, a net margin of -8.6%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (4/5); the weakest is financial health (0/5).
Key numbers: 5-year revenue growth of 15% a year, a 5-year average ROIC of -89%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 6% above the current price.
About Uxin
Uxin is listed in the US and classified in business services, IPO year 2018. Revenue went from $483M in 2018 to $463M in 2025, a decline of about 0.6% a year. It was profitable in 0 of the last 7 years in our data. It spends 0% of revenue on research and development.
Score: 1.6 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- ROE above 15%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | $463M | $190M | $300M | $258M | $100M | $228M | $483M |
| Net income | -$40M | -$52M | -$20M | -$23M | -$64M | -$285M | -$222M |
| Free cash flow | -$75M | -$38M | -$41M | -$136M | -$171M | -$178M | -$352M |
| EPS (diluted) | $-0.18 | $-0.23 | $-0.09 | $-0.10 | $-0.29 | $-1.30 | $-1.01 |
| Net margin | -8.6% | -27.1% | -6.7% | -8.8% | -64.1% | -125.2% | -45.9% |
| ROIC | -29.2% | -148.7% | — | — | — | -126.7% | -58.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Uxin stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 6% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Uxin pay a dividend?
Not currently.
Is Uxin a good stock to buy?
We do not give buy or sell advice. Uxin scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.